579 related articles for article (PubMed ID: 26825555)
1. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
2. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
[TBL] [Abstract][Full Text] [Related]
3. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
4. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.
Flenner F; Friedrich FW; Ungeheuer N; Christ T; Geertz B; Reischmann S; Wagner S; Stathopoulou K; Söhren KD; Weinberger F; Schwedhelm E; Cuello F; Maier LS; Eschenhagen T; Carrier L
Cardiovasc Res; 2016 Jan; 109(1):90-102. PubMed ID: 26531128
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.
Kumar M; Govindan S; Zhang M; Khairallah RJ; Martin JL; Sadayappan S; de Tombe PP
J Biol Chem; 2015 Dec; 290(49):29241-9. PubMed ID: 26453301
[TBL] [Abstract][Full Text] [Related]
7. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart.
Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X
Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascade.
Guillory AN; Yin X; Wijaya CS; Diaz Diaz AC; Rababa'h A; Singh S; Atrooz F; Sadayappan S; McConnell BK
PLoS One; 2013; 8(9):e74784. PubMed ID: 24058627
[TBL] [Abstract][Full Text] [Related]
10. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.
Cazorla O; Szilagyi S; Vignier N; Salazar G; Krämer E; Vassort G; Carrier L; Lacampagne A
Cardiovasc Res; 2006 Feb; 69(2):370-80. PubMed ID: 16380103
[TBL] [Abstract][Full Text] [Related]
11. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
van Dijk SJ; Paalberends ER; Najafi A; Michels M; Sadayappan S; Carrier L; Boontje NM; Kuster DW; van Slegtenhorst M; Dooijes D; dos Remedios C; ten Cate FJ; Stienen GJ; van der Velden J
Circ Heart Fail; 2012 Jan; 5(1):36-46. PubMed ID: 22178992
[TBL] [Abstract][Full Text] [Related]
12. Identifying a role of the actin capping protein CapZ in β-adrenergic receptor signalling.
Gaikis L; Stewart D; Johnson R; Pyle WG
Acta Physiol (Oxf); 2013 Jan; 207(1):173-82. PubMed ID: 22882973
[TBL] [Abstract][Full Text] [Related]
13. Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium.
Boontje NM; Merkus D; Zaremba R; Versteilen A; de Waard MC; Mearini G; de Beer VJ; Carrier L; Walker LA; Niessen HW; Dobrev D; Stienen GJ; Duncker DJ; van der Velden J
J Mol Cell Cardiol; 2011 Mar; 50(3):487-99. PubMed ID: 21156182
[TBL] [Abstract][Full Text] [Related]
14. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
15. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
[TBL] [Abstract][Full Text] [Related]
16. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.
Sulakhe PV; Vo XT
Mol Cell Biochem; 1995; 149-150():103-26. PubMed ID: 8569720
[TBL] [Abstract][Full Text] [Related]
17. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.
Schlossarek S; Schuermann F; Geertz B; Mearini G; Eschenhagen T; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):5-15. PubMed ID: 22076249
[TBL] [Abstract][Full Text] [Related]
19. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
[TBL] [Abstract][Full Text] [Related]
20. Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.
Najafi A; Schlossarek S; van Deel ED; van den Heuvel N; Güçlü A; Goebel M; Kuster DW; Carrier L; van der Velden J
Pflugers Arch; 2015 Jun; 467(6):1303-17. PubMed ID: 25010737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]